Company registration number 11030072 (England and Wales)
ARLINGTON CARE GROUP LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2023
PAGES FOR FILING WITH REGISTRAR
ARLINGTON CARE GROUP LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 5
ARLINGTON CARE GROUP LIMITED
BALANCE SHEET
AS AT
31 OCTOBER 2023
31 October 2023
- 1 -
2023
2022
Notes
£
£
£
£
Fixed assets
Tangible assets
3
1,590,415
1,514,929
Current assets
Debtors
4
976,337
763,800
Cash at bank and in hand
2,454
182
978,791
763,982
Creditors: amounts falling due within one year
5
(2,561,927)
(2,259,506)
Net current liabilities
(1,583,136)
(1,495,524)
Total assets less current liabilities
7,279
19,405
Creditors: amounts falling due after more than one year
6
(25,315)
(28,072)
Net liabilities
(18,036)
(8,667)
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
(18,136)
(8,767)
Total equity
(18,036)
(8,667)

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 October 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 31 October 2024 and are signed on its behalf by:
A Sandhu
Director
Company Registration No. 11030072
ARLINGTON CARE GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2023
- 2 -
1
Accounting policies
Company information

Arlington Care Group Limited is a private company limited by shares incorporated in England and Wales. The registered office is Sandhu House, Delves Lane, Consett, County Durham, DH8 7BA.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

At the date of the balance sheet the company had net liabilities of £18,036.true

 

At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Freehold land and buildings
No depreciation as the asset is still under construction
Fixtures and fittings
15% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.5
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

ARLINGTON CARE GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2023
1
Accounting policies
(Continued)
- 3 -
Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.6
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2023
2022
Number
Number
Total
-
0
-
0
ARLINGTON CARE GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2023
- 4 -
3
Tangible fixed assets
Land and buildings
Plant and machinery etc
Total
£
£
£
Cost
At 1 November 2022
1,500,000
15,444
1,515,444
Additions
60,489
19,614
80,103
At 31 October 2023
1,560,489
35,058
1,595,547
Depreciation and impairment
At 1 November 2022
-
0
515
515
Depreciation charged in the year
-
0
4,617
4,617
At 31 October 2023
-
0
5,132
5,132
Carrying amount
At 31 October 2023
1,560,489
29,926
1,590,415
At 31 October 2022
1,500,000
14,929
1,514,929
4
Debtors
2023
2022
Amounts falling due within one year:
£
£
Amounts owed by group undertakings
976,337
763,800
5
Creditors: amounts falling due within one year
2023
2022
£
£
Bank loans
7
10,359
10,292
Trade creditors
-
0
1,980
Other creditors
2,549,268
2,244,827
Accruals and deferred income
2,300
2,407
2,561,927
2,259,506
6
Creditors: amounts falling due after more than one year
2023
2022
Notes
£
£
Bank loans and overdrafts
7
25,315
28,072
ARLINGTON CARE GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2023
- 5 -
7
Loans and overdrafts
2023
2022
£
£
Bank loans
35,674
38,364
Payable within one year
10,359
10,292
Payable after one year
25,315
28,072
8
Related party transactions

Arlington Care Group Limited is a subsidiary of Jonathan Mann Developments Limited. During the year Jonathan Mann Developments Limited was constructing a care home on behalf of Arlington Care Group Limited. No sale has been made in the year for these sevices, upon completion there will be a final sale of building services from Jonathan Mann Developments Limited to Arlington Care Group Limited.

 

At the year end Arlington Care Group Limited was owed £983,427 from Jonathan Mann Developments Limited.

2023-10-312022-11-01false31 October 2024CCH SoftwareCCH Accounts Production 2024.210No description of principal activityA SandhuK KaurK Singhfalsefalse110300722022-11-012023-10-31110300722023-10-31110300722022-10-3111030072core:LandBuildings2023-10-3111030072core:OtherPropertyPlantEquipment2023-10-3111030072core:LandBuildings2022-10-3111030072core:OtherPropertyPlantEquipment2022-10-3111030072core:CurrentFinancialInstrumentscore:WithinOneYear2023-10-3111030072core:CurrentFinancialInstrumentscore:WithinOneYear2022-10-3111030072core:Non-currentFinancialInstrumentscore:AfterOneYear2023-10-3111030072core:Non-currentFinancialInstrumentscore:AfterOneYear2022-10-3111030072core:CurrentFinancialInstruments2023-10-3111030072core:CurrentFinancialInstruments2022-10-3111030072core:ShareCapital2023-10-3111030072core:ShareCapital2022-10-3111030072core:RetainedEarningsAccumulatedLosses2023-10-3111030072core:RetainedEarningsAccumulatedLosses2022-10-3111030072bus:Director12022-11-012023-10-3111030072core:LandBuildingscore:OwnedOrFreeholdAssets2022-11-012023-10-3111030072core:FurnitureFittings2022-11-012023-10-31110300722021-11-012022-10-3111030072core:LandBuildings2022-10-3111030072core:OtherPropertyPlantEquipment2022-10-31110300722022-10-3111030072core:LandBuildings2022-11-012023-10-3111030072core:OtherPropertyPlantEquipment2022-11-012023-10-3111030072core:Non-currentFinancialInstruments2023-10-3111030072core:Non-currentFinancialInstruments2022-10-3111030072bus:PrivateLimitedCompanyLtd2022-11-012023-10-3111030072bus:SmallCompaniesRegimeForAccounts2022-11-012023-10-3111030072bus:FRS1022022-11-012023-10-3111030072bus:AuditExemptWithAccountantsReport2022-11-012023-10-3111030072bus:Director22022-11-012023-10-3111030072bus:Director32022-11-012023-10-3111030072bus:FullAccounts2022-11-012023-10-31xbrli:purexbrli:sharesiso4217:GBP